FDA NDC Directory · JSON-LD · Markdown

Anthim

NDC 69604-204 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameobiltoxaximab
Labeler / ManufacturerElusys Therapeutics, Inc.
Marketing categoryBiologic License Application · App BLA125509
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsOBILTOXAXIMAB (100 mg/mL)
Marketing started20160318
Package count1

External sources

Source: openFDA. Public-domain (CC0).